Giulia Vitali

Giulia Vitali

Auto-generated profile, based on publicly available information

Giulia Vitali

Department of Paediatric Emergency Care, DM’UP, APHP, Hôpital Robert Debré, Paris, France

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2022 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
LLLea Lenglart
Lea Lenglart
VRVincenzo Raieli
Vincenzo Raieli
VSvittorio sciruicchio
vittorio sciruicchio
CCCaroline Caula
Caroline Caula
GVGiulia Vitali
Giulia Vitali
Luigi TitomanlioLuigi Titomanlio
Luigi Titomanlio

8 September 2018 in Updates in Surgery
Verified
Journal Article
Closed access
PDF file
MRMatteo Rottoli
Matteo Rottoli
BCBenedetta Casadei
Benedetta Casadei
CVCarlo Vallicelli
Carlo Vallicelli
GVGiulia Vitali
Giulia Vitali
FGFederico Ghignone
Federico Ghignone
GPGilberto Poggioli
Gilberto Poggioli

1 November 2012 in Reviews on Recent Clinical Trials
Verified
Journal Article
Closed access
PDF file
PGPaolo Gionchetti
Paolo Gionchetti
ACA. Calafiore
A. Calafiore
CPChiara Pratico'
Chiara Pratico'
SLSilvio Laureti
Silvio Laureti
GVG. Vitali
G. Vitali
FRFernando Rizzello
Fernando Rizzello
Pouchitis is the most common complication of Proctocolectomy with ileal pouch-anal anastomosis (IPAA) in patients with ulcerative colitis (UC). The diagnosis of pouchitis requires the presence of symptoms, together with characteristic endoscopic and histological abnormalities. The exact cause of pouchitis is not known. Whereas ‘acute’ pouchitis can be treated rapidly and successfully in the majority of patients, ‘‘refractory’’ and ‘chronic pouchitis’’ remain therapeutic challenges to patients and physicians. Metronidazole and Ciprofloxacin budesonide enemas and oral probiotic therapy with VSL#3 all appear to be effective therapies for acute and/or chronic pouchitis. The medical therapy of pouchitis remains largely empiric, and additional multicenter, randomized, double-blind, placebo-con- trolled, dose-ranging trials are needed. In future trials, treatment indications such as active acute or chronic pouchitis and maintenance of remission for acute or chronic pouchitis should be clearly defined.